Single dose of Sputnik V Covid vaccine triggers strong antibody response: Study


PTI, Jul 14, 2021, 1:13 PM IST

London:  A single dose of the Sputnik V vaccine may be enough to elicit a strong antibody response against SARS-CoV-2, the virus that causes COVID-19, in already infected people, according to a study.

Previous studies have found that two doses of Sputnik V, a vector vaccine produced using a combination of two adenoviruses, results in 92 percent efficacy against COVID-19 infection.

Adenoviruses are common viruses that cause a range of illnesses with cold-like symptoms such as fever and sore throat.

The new study, published on Tuesday in the journal Cell Reports Medicine, examined whether a single dose would achieve greater public health benefit than two doses by allowing the protection of a larger population more quickly.

“Due to limited vaccine supply and uneven vaccine distribution in many regions of the world, health authorities urgently need data on the immune response to vaccines to optimize vaccination strategies,” said study senior author Andrea Gamarnik of the Fundacion Instituto Leloir-CONICET in Buenos Aires, Argentina.

“The peer-reviewed data we present provide information for guiding public health decisions in light of the current global health emergency,” Gamarnik said.

The researchers noted that evidence from other vaccines offers support for the one-shot approach.

The AstraZeneca vaccine, for example, shows 76 percent efficacy after a single dose, and the Moderna and Pfizer vaccines may induce sufficient immunity in previously infected individuals after one dose, with no apparent benefit of an additional dose, they said.

In the latest study, the researchers compared the effects of one and two shots of Sputnik V on SARS-CoV-2-specific antibody responses in 289 healthcare workers in Argentina.

Three weeks after the second dose, all volunteers with no prior infection generated virus-specific immunoglobulin G (IgG) antibodies — the most common type of antibody found in the blood.

However, even within three weeks of receiving the first dose, 94 percent of these participants developed IgG antibodies against the virus, and 90 percent showed evidence of neutralizing antibodies, which interfere with the ability of viruses to infect cells.

The research further showed that IgG and neutralizing antibody levels in previously infected participants were significantly higher after one dose than those in fully vaccinated volunteers with no history of infection.

A second dose did not increase the production of neutralizing antibodies in previously infected volunteers.

“This highlights the robust response to vaccination of previously infected individuals, suggesting that naturally acquired immunity might be enhanced sufficiently by a single dose, in agreement with recent studies using mRNA vaccines,” Gamarnik said.

The researchers noted that further studies are needed to evaluate the duration of the immune response and to assess how antibody levels relate to vaccine protection against COVID-19.

The high antibody levels after a single dose in naive participants suggest a benefit of delaying second dose administration to increase the number of people vaccinated, they said.

“Evidence-based on quantitative information will guide vaccine deployment strategies in the face of worldwide vaccine supply restriction,” Gamarnik added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

BRS has no plans to contest K’taka Assembly polls: Kumaraswamy

Karnataka govt to open ‘Namma Clinics’ in the state

Hindi trailer of Rishab Shetty-starrer ‘Kantara’ ready for release on Oct 9

India’s heaviest rocket to make global foray on October 22

SA score 249 for 4 against India in rain-curtailed first ODI

BJP to hold mega events, tour programmes of key party leaders ahead of elections in Karnataka

‘Even my wife doesn’t scold me as much as LG sahib’: Kejriwal asks Saxena to ‘chill a bit’


Related Articles More

Compound in some mouthwashes may suppress COVID-19, study finds

BA.2 variant in around 90% Covid samples genome-sequenced in Delhi in July-Aug

WHO alert for four Indian syrups as 66 children die in Gambia

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

Labcorp Drug Development selects Dr. Deepa Desai as Country head for India

MUST WATCH

Running Reace with Rahul Gandi and Siddaramiah

Uchila Dasara 2022 : Final Preparation for Precession

Bharath Judo : Rahul Gandhi Speach in Rain

Day 8 | Mahagauri

Sarapady Devadas Special Video.


Latest Additions

UNHRC adopts resolution against Sri Lanka’s rights record; India abstains from voting

Foreign vessel with drugs seized off Kochi coast

BRS has no plans to contest K’taka Assembly polls: Kumaraswamy

Karnataka govt to open ‘Namma Clinics’ in the state

Gold worth Rs 38.53 Lakhs seized from passenger at MIA

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.